NIPT Testing Timing Decision Algorithm Based on K-means Clustering and Multi-Objective Risk Optimization
DOI:
https://doi.org/10.54097/dz3jjf38Keywords:
Non-invasive prenatal testing, Point-in-time optimization, K-means clustering, Risk function, Random forestAbstract
The accuracy of non-invasive prenatal testing (NIPT) is highly dependent on fetal cell-free DNA concentrations, especially the 4% threshold for male Y chromosome concentrations. To optimize the timing of detection and minimize clinical risks, this paper proposes a data-driven decision-making framework. Firstly, the relationship between Y chromosome concentration and 21 characteristics such as gestational age and BMI was explored by Spearman rank correlation analysis and random forest regression model, and it was found that X chromosome concentration had the most significant effect. Secondly, a K-means clustering method based on standardized BMI was proposed for male fetal samples, and a comprehensive objective function combining early detection risk, failure risk, error risk and delay punishment was constructed to determine the optimal gestational age detection in each group. The results showed that the recommended testing time point for the low-to-medium BMI group (20.7-35.9) was about 14.9 weeks, while the high BMI group (36.3-45.7) needed to be delayed to 18.2 weeks, and the overall robust success rate was 0.849. Finally, the population was subdivided into four groups, with the optimal time point distributed from 14.1 to 18.5 weeks, and the overall robust success rate reached 0.863, of which the "standard compliance ratio" was identified as the most critical feature. This study provides a systematic algorithm solution for personalized NIPT detection time point planning.
Downloads
References
[1] Gil M M, et al. Analysis of cell-free DNA in maternal blood in screening for fetal aneuploidies: updated meta-analysis. Ultrasound Obstet Gynecol, 2020, 55(3): 302-314.
[2] Hui L, et al. Clinical implementation of cell-free DNA-based aneuploidy screening: perspectives from a multinational survey. Prenat Diagn, 2022, 42(8): 975-986.
[3] Yaron Y. The implications of non-invasive prenatal testing failures: a review of an under-discussed phenomenon. Prenat Diagn, 2020, 40(6): 677-683.
[4] Wang E, et al. Gestational age and maternal weight effects on fetal cell-free DNA in maternal plasma. Prenat Diagn, 2021, 41(7): 810-817.
[5] Hudecova I, et al. Maternal plasma fetal DNA fractions in pregnancies with low and high maternal BMI: implications for noninvasive prenatal testing. Prenat Diagn, 2022, 42(1): 54-61.
[6] Norton M E, et al. Cell-free DNA analysis for noninvasive examination of trisomy. N Engl J Med, 2015, 372(17): 1589-1597.
[7] Esteva A, et al. A guide to deep learning in healthcare. Nat Med, 2019, 25(1): 24-29.
[8] Deo R C. Machine Learning in Medicine. Circulation, 2015, 132(20): 1920-1930.
[9] López-Moral A, et al. Machine learning techniques for non-invasive prenatal testing: a systematic review. Bioinform Biol Insights, 2023, 17: 11779322231152420.
[10] Breiman L. Random Forests. Machine Learning, 2001, 45(1): 5-32.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Journal of Computing and Electronic Information Management

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.








